We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Price loading...
Birkhauser New Therapeutic Targets in Rheumatoid Arthritis (Progress in Inflammation Research)
Price data last checked 102 day(s) ago - refreshing...
Price History & Forecast
No Price Data Available
Price history will appear here once data is collected from Amazon.
Price Distribution
No price data available for histogram
Description
During the past decades important breakthroughs have been made in the treatment of rheumatoid arthritis (RA). First, the implementation of low-dose methotrexate and other conventional disease-modifying anti-rheumatic drugs was introduced as an effective treatment. Second, it was recognized that early immunomodu- tory treatment is crucial for controlling the disease and its long-term destructive effects more effectively. Parallel advances in research on the pathogenesis of RA and cytokine biology converged in identifying tumor necrosis factor (TNF) as a key factor in inflammation and matrix destruction. The concept arose that elevated TNF concentrations at the sites of inflammation were driving disease pathology, and the removal of excess TNF from sites of inflammation became a therapeutic goal. Clearly, TNF blockade has revolutionized the treatment of RA, as well as other immune-mediated inflammatory diseases. Anti-TNF treatment results in cli- cal benefit in a significant proportion of the patients, and it has provided proof of concept for the principle of targeted therapy. Despite the impressive disease-modifying effects of the TNF blockers, not all patients respond, and patients who exhibited an initial response may lose response due to the development of anti-drug antibodies (human anti-chimeric antibodies and human anti-human antibodies, respectively) and perhaps as a result of escape mechanisms related to the disease process. In fact, the majority of the patients still have disease activity in at least one or two actively inflamed joints.
Product Specifications
- Brand
- Birkhauser
- Format
- hardcover
- ASIN
- 3764382376
- Domain
- Amazon UK
- Release Date
- 13 March 2009
- Listed Since
- 03 September 2007
Barcode
No barcode data available
Similar Products You Might Like
94% match
Biologics in Rheumatology: New Developments, Clinical Uses & Health Implication
£232.30
12 Jan 2026
93% match
Addressing Unmet Medical Needs in Rheumatoid Arthritis
£115.00
08 Jan 2026
93% match
The Handbook of Biological Therapy
Oxford University Press
£15.20
06 Mar 2026
93% match
Gene Therapy in Inflammatory Diseases (Progress in Inflammation Research)
Birkhauser
£76.94
08 Mar 2026
93% match
Next-Generation Therapies and Technologies for Immune-Mediated Inflammatory Diseases (Progress in Inflammation Research)
Springer
£107.85
09 Mar 2026
93% match
Arthritis: Models and Mechanisms
Springer
£85.28
08 Mar 2026
93% match
Clinical Trials in Rheumatoid Arthritis and Osteoarthritis
Springer
£88.04
01 Mar 2026
93% match
Tumor Necrosis Factor (Cell Biology Research Progress)
£15.50
14 Feb 2026
93% match
Disease-modifying Therapy in Vasculitides (Progress in Inflammation Research)
Birkhauser
£109.47
08 Mar 2026
93% match
Modern Therapeutics in Rheumatic Diseases
Humana
£46.92
19 Apr 2026
93% match
Clinical Innovation in Rheumatology: Past, Present, and Future
£51.44
11 Jan 2026
93% match
Immunology of Rheumatic Diseases
Springer
£78.52
08 Mar 2026
93% match
Apoptosis and Inflammation (Progress in Inflammation Research)
Birkhauser
£144.41
09 Dec 2025
93% match
The Heart in Rheumatic, Autoimmune and Inflammatory Diseases: Pathophysiology, Clinical Aspects and Therapeutic Approaches
Academic Press
£102.69
05 Feb 2026
93% match
Pharmacology of Immunotherapeutic Drugs
Springer
£96.18
11 Jan 2026
92% match
Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy: A Handbook for Diagnosis and Management
Springer
£84.69
10 Mar 2026
92% match
Modern Immunosuppressives (Milestones in Drug Therapy)
Birkhauser
£80.56
08 Mar 2026
92% match
Apoptosis and Inflammation (Progress in Inflammation Research)
Birkhauser
£38.21
03 Mar 2026
92% match
New Targets in Inflammation: Inhibitors of COX-2 or Adhesion Molecules
Springer
£77.75
23 Feb 2026
92% match
Inflammation Research Perspectives
£71.23
08 Mar 2026
92% match
Recent Developments in Anti-Inflammatory Therapy
Academic Press
£80.86
09 Mar 2026
92% match
Arthritis: Pathophysiology, Prevention, and Therapeutics
CRC Press
£63.78
03 Apr 2026
92% match
Autoantigens (Section B) (Manual of Biological Markers of Disease)
Springer
£78.46
10 Feb 2026
92% match
Immunology and Rheumatology in Questions
Springer
£84.31
31 Jan 2026